LeMaitre Vascular, Inc. (LMAT) — Analyst outlook / Analyst consensus target is. Based on 20 analyst ratings, the consensus is bullish — 14 Buy, 6 Hold.
The consensus price target is $101.50 (low: $95.00, high: $108.00), representing a downside of 13.5% from the current price $117.39.
Analysts estimate Earnings Per Share (EPS) of $1.94 and revenue of $0.22B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $1.96 vs est $1.94 (beat +1%). 2025: actual $2.55 vs est $2.46 (beat +3.5%). Analyst accuracy: 98%.
LMAT Stock — 12-Month Price Forecast
$101.50
▼ -13.54% Downside
Average Price Target
Based on 20 Wall Street analysts offering 12-month price targets for LeMaitre Vascular, Inc., the average price target is $101.50, with a high forecast of $108.00, and a low forecast of $95.00.
The average price target represents a -13.54% change from the last price of $117.39.
Highest Price Target
$108.00
Average Price Target
$101.50
Lowest Price Target
$95.00
LMAT Analyst Ratings
Buy
Based on 20 analysts giving stock ratings to LeMaitre Vascular, Inc. in the past 3 months
EPS Estimates — LMAT
98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $1.96
vs Est $1.94
▲ 1.0% off
2025
Actual $2.55
vs Est $2.46
▲ 3.3% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is improving.
Revenue Estimates — LMAT
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.220B
vs Est $0.220B
▼ 0.1% off
2025
Actual $0.250B
vs Est $0.248B
▲ 0.6% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
